# Trade Mark Journal No.2026/009 27 February 2026

## WO0000001885369 (42,44)

Office of origin: United States of America

Date of International Registration:7 October 2025
Date of designation in the UK: 7 October 2025

International priority date claimed: 7 April 2025 (United States of America) (99124433)

Class 42
  Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS).
Class 44
  Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS).

Caris MPI, Inc.

Representative: Haseltine Lake Kempner LLP, Fountain House, 4 South Parade Leeds LS1 5QX UNITED KINGDOM